What dose of Finerenone (Kerendia) is used at eGFR <15?

At <15 mL/min/1.73m² (not on dialysis), the recommended dose of Finerenone (Kerendia) is: Not recommended for de novo initiation below eGFR 15.

Is Finerenone (Kerendia) safe in kidney disease at eGFR <15?

Limited evidence; a nephrologist decides on continuation. This table is dosing guidance for planning — the final dose is confirmed by your prescriber, and kidney function and the drug's own monitoring requirements are rechecked regularly.

What should I check while taking Finerenone (Kerendia) at eGFR <15?

Follow the drug's label monitoring — typically kidney function (eGFR/creatinine), and for many drugs potassium, drug levels, or blood counts as applicable. Report any new symptoms such as weakness, irregular heartbeat, or unusual side effects to your doctor.

What dose of Finerenone (Kerendia) is used at eGFR <15?

At <15 mL/min/1.73m² (not on dialysis), the recommended dose of Finerenone (Kerendia) is: Not recommended for de novo initiation below eGFR 15.

Is Finerenone (Kerendia) safe in kidney disease at eGFR <15?

Limited evidence; a nephrologist decides on continuation. This table is dosing guidance for planning — the final dose is confirmed by your prescriber, and kidney function and the drug's own monitoring requirements are rechecked regularly.

What should I check while taking Finerenone (Kerendia) at eGFR <15?

Follow the drug's label monitoring — typically kidney function (eGFR/creatinine), and for many drugs potassium, drug levels, or blood counts as applicable. Report any new symptoms such as weakness, irregular heartbeat, or unusual side effects to your doctor.

Renal Dosing Guide

Finerenone (Kerendia) Dosing at eGFR <15

Kerendia • Nonsteroidal mineralocorticoid receptor antagonist • Kidney function: <15 mL/min/1.73m² (not on dialysis)

The recommended dose of Finerenone (Kerendia) at <15 mL/min/1.73m² (not on dialysis) — with monitoring notes for kidney disease and dialysis.

Recommended dose at eGFR <15

Not recommended for de novo initiation below eGFR 15.

Limited evidence; a nephrologist decides on continuation.

Dosing at Other Kidney Function Levels

Finerenone (Kerendia) at eGFR ≥45

≥45 mL/min/1.73m² (or CrCl >50)

View dose

Finerenone (Kerendia) at eGFR 30–44

30–44 mL/min/1.73m² (or CrCl 30–50)

View dose

Finerenone (Kerendia) at eGFR 15–29

15–29 mL/min/1.73m² (or CrCl 15–29)

View dose

Finerenone (Kerendia) at On dialysis

Hemodialysis or peritoneal dialysis

View dose

How dosing is decided

Doses in this guide follow drug labels and renal-dosing references at each eGFR/CrCl level. Always confirm with your prescriber and pharmacy — your specific dose depends on other medications, conditions, and lab results.

Full Finerenone (Kerendia) kidney guide

Monitoring reminder

Finerenone (Kerendia) has its own monitoring requirements (eGFR, potassium, drug levels, or blood counts). These become more frequent as kidney function falls. Report unusual weakness, irregular heartbeat, or new side effects promptly.

Interactive drug-dosing tool